Literature DB >> 17316076

Role of apoptosis in low-dose hyper-radiosensitivity.

S A Krueger1, M C Joiner, M Weinfeld, E Piasentin, B Marples.   

Abstract

Little is known about the mode of cell killing associated with low-dose hyper-radiosensitivity, the radiation response that describes the enhanced sensitivity of cells to small doses of ionizing radiation. Using a technique that measures the activation of caspase 3, we have established a relationship between apoptosis detected 24 h after low-dose radiation exposure and low-dose hyper-radiosensitivity in four mammalian cell lines (T98G, U373, MR4 and 3.7 cells) and two normal human lymphoblastoid cell lines. The existence of low-dose hyper-radiosensitivity in clonogenic survival experiments was found to be associated with an elevated level of apoptosis after low-dose exposures, corroborating earlier observations (Enns et al., Mol. Cancer Res. 2, 557-566, 2004). We also show that enriching populations of MR4 and V79 cells with G(1)-phase cells, to minimize the numbers of G(2)-phase cells, abolished the enhanced low-dose apoptosis. These cell-cycle enrichment experiments strengthen the reported association between low-dose hyper-sensitivity and the radioresponse of G(2)-phase cells. These data are consistent with our current hypothesis to explain low-dose hyper-radiosensitivity, namely that the enhanced sensitivity of cells to low doses of ionizing radiation reflects the failure of ATM-dependent repair processes to fully arrest the progression of damaged G(2)-phase cells harboring unrepaired DNA breaks entering mitosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316076     DOI: 10.1667/RR0776.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  22 in total

1.  Radiobiological Response of Cervical Cancer Cell Line in Low Dose Region: Evidence of Low Dose Hypersensitivity (HRS) and Induced Radioresistance (IRR).

Authors:  Saikat Das; Rabiraja Singh; Daicy George; T S Vijaykumar; Subhashini John
Journal:  J Clin Diagn Res       Date:  2015-06-01

2.  Low dose hyper-radiosensitivity in human lung cancer cell line A549 and its possible mechanisms.

Authors:  Xiaofang Dai; Dan Tao; Hongge Wu; Jing Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

3.  Non-problematic risks from low-dose radiation-induced DNA damage clusters.

Authors:  Daniel P Hayes
Journal:  Dose Response       Date:  2008-01-16       Impact factor: 2.658

4.  The linear no-threshold relationship is inconsistent with radiation biologic and experimental data.

Authors:  Maurice Tubiana; Ludwig E Feinendegen; Chichuan Yang; Joseph M Kaminski
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

5.  Association of ATM activation and DNA repair with induced radioresistance after low-dose irradiation.

Authors:  L Enns; A Rasouli-Nia; M Hendzel; B Marples; M Weinfeld
Journal:  Radiat Prot Dosimetry       Date:  2015-04-22       Impact factor: 0.972

Review 6.  Assessing cancer risks of low-dose radiation.

Authors:  Leon Mullenders; Mike Atkinson; Herwig Paretzke; Laure Sabatier; Simon Bouffler
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

7.  Sensitivity to low-dose/low-LET ionizing radiation in mammalian cells harboring mutations in succinate dehydrogenase subunit C is governed by mitochondria-derived reactive oxygen species.

Authors:  Nukhet Aykin-Burns; Benjamin G Slane; Annie T Y Liu; Kjerstin M Owens; Malinda S O'Malley; Brian J Smith; Frederick E Domann; Douglas R Spitz
Journal:  Radiat Res       Date:  2010-11-17       Impact factor: 2.841

8.  Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment.

Authors:  Alexander M Vaiserman
Journal:  Dose Response       Date:  2010-01-18       Impact factor: 2.658

9.  VorinostatSAHA Promotes Hyper-Radiosensitivity in Wild Type p53 Human Glioblastoma Cells.

Authors:  Eric Diss; NarasimhaRao Nalabothula; Duc Nguyen; Elizabeth Chang; Young Kwok; France Carrier
Journal:  J Clin Oncol Res       Date:  2014-01-15

10.  MRI evaluation of neoadjuvant low-dose fractionated radiotherapy with concurrent chemotherapy in patients with locally advanced breast cancer.

Authors:  E Bufi; P Belli; M Costantini; P Rinaldi; M Di Matteo; A Bonatesta; M C De Santis; L Nardone; D Terribile; A Mulé; L Bonomo
Journal:  Br J Radiol       Date:  2012-07-04       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.